Jeff DeMartino

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Ejection Fraction

Long Non Coding Rna

Top Venues

EMBO molecular medicine

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Lin, Jeff DeMartino, Daisong Wang, Gijs J F van Son, Reinier van der Linden, Harry Begthel, Jeroen Korving, Amanda Andersson-Rolf, Stieneke van den Brink, Carmen Lopez-Iglesias, Willine J van de Wetering, Aleksandra Balwierz, Thanasis Margaritis, Marc van de Wetering, Peter J Peters, Jarno Drost, Johan H van Es, Hans Clevers
Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation. Science (New York, N.Y.) 382 (6669) (2023)
Jeff DeMartino, Michael T Meister, Lindy L Visser, Mariël Brok, Marian Groot Koerkamp, Amber K L Wezenaar, Laura S Hiemcke-Jiwa, Terezinha de Souza, Johannes Hendrikus Maria Merks, Anne C Rios, Frank C P Holstege, Thanasis Margaritis, Jarno Drost
Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma. Nature communications 14 (1) (2023)
Michael T Meister, Marian Groot Koerkamp, Terezinha de Souza, Willemijn B Breunis, Ewa Frazer-Mendelewska, Mariël Brok, Jeff DeMartino, Freek Manders, Camilla Calandrini, Hinri H D Kerstens, Alex Janse, M Emmy M Dolman, Selma Eising, Karin P S Langenberg, Marc van Tuil, Rutger R G Knops, Sheila Terwisscha van Scheltinga, Laura S Hiemcke-Jiwa, Uta Flucke, Johannes Hendrikus Maria Merks, Max M Van Noesel, Bastiaan B J Tops, Jayne Y Hehir-Kwa, Patrick Kemmeren, Jan J Molenaar, Marc van de Wetering, Ruben van Boxtel, Jarno Drost, Frank C P Holstege
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes. EMBO molecular medicine 14 (10) (2022)